Abstract i-SANEX is a process for separating actinides(III) from used nuclear fuels by solvent extraction: Actinides(III) and lanthanides(III) are co-extracted from a PUREX raffinate followed by selective back extraction of actinides(III) from the loaded organic phase. This step requires a complexing agent selective for actinides(III). A hydrophilic sulfonated bis triazinyl pyridine (SO3-Ph-BTP) was synthesized and tested for selective complexation of actinides(III) in nitric acid solution. When co-extracting Am(III) and Eu(III) from nitric acid into TODGA, adding SO3-Ph-BTP to the aqueous phase suppresses Am(III) extraction while Eu(III) is extracted. Separation factors in the range of 1000 are achieved. SO3-Ph-BTP remains active in nitric acid up to 2 mol/L. As a result of this performance, buffering or salting-out agents are not needed in the aqueous phase; nitric acid is used to keep the lanthanides(III) in the TODGA solvent. These properties make SO3-Ph-BTP a suitable candidate for i-SANEX process development. Keywords: i-SANEXliquid-liquid extractionaqueous complexationhydrophilic BTPactinides(III)lanthanides(III)separationnitric acid ACKNOWLEDGMENT Financial support from the Commission of the European Community (project ACSEPT, FP7-CP-2007-211 267) and the German Federal Ministry of Education and Research (BMBF contract numbers 02NUK012A and 02NUK012E) is acknowledged. ESI-MS analysis of SO3-Ph-BTP was kindly performed by D. Girnt, Karlsruher Institut für Technologie, Institut für Anorganische Chemie.
No takes yet. Share an insight, caveat, or question.
Geist et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: